A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells

被引:57
作者
Taylor, Graham S. [1 ]
Long, Heather M. [1 ]
Haigh, Tracey A. [1 ]
Larsen, Martin [1 ]
Brooks, Jill [1 ]
Rickinson, Alan B. [1 ]
机构
[1] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.177.6.3746
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD4(+) T cell response to EBV may have an important role in controlling virus-driven B lymphoproliferation because CD4(+) T cell clones to a subset of EBV nuclear Ag (EBNA) epitopes can directly recognize virus-trinsformed lymphoblastoid. cell lines (LCLs) in vitro and inhibit their growth. In this study, we used a panel of EBNA1, 2, 3A, and 3C-specific CD4(+) T cell clones to study the route whereby endogenously expressed EBNAs access the HLA class II-presentation pathway. Two sets of results spoke against a direct route of intracellular access. First, none of the clones recognized cognate Ag overexpressed in cells from vaccinia vectors but did recognize Ag fused to an endo/lysosomal targeting sequence. Second, focusing on clones with the strongest LCL recognition that were specific for EBNA2- and EBNA3C-derived epitopes LCL recognition was unaffected by inhibiting autophagy, a postulated route for intracellular Ag delivery into the HLA class II pathway in LCL cells. Subsequently, using these same epitope-specific clones, we found that Ag-negative cells with the appropriate HLA-restricting allele could be efficiently sensitized to CD4(+) T cell recognition by cocultivation with Ag-positive donor lines or by exposure to donor line-conditioned culture medium. Sensitization was mediated by a high m.w. antigenic species and required active Ag processing by recipient cells. We infer that intercellular Ag transfer plays a major role in the presentation of EBNA-derived CD4 epitopes by latently infected target cells.
引用
收藏
页码:3746 / 3756
页数:11
相关论文
共 56 条
[31]   Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins [J].
Lich, JD ;
Elliott, JF ;
Blum, JS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) :1513-1523
[32]   CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines [J].
Long, HM ;
Haigh, TA ;
Gudgeon, NH ;
Leen, AM ;
Tsang, CW ;
Brooks, J ;
Landais, E ;
Houssaint, E ;
Lee, SP ;
Rickinson, AB ;
Taylor, GS .
JOURNAL OF VIROLOGY, 2005, 79 (08) :4896-4907
[33]   PROCESSING PATHWAYS FOR PRESENTATION OF CYTOSOLIC ANTIGEN TO MHC CLASS-II-RESTRICTED T-CELLS [J].
MALNATI, MS ;
MARTI, M ;
LAVAUTE, T ;
JARAQUEMADA, D ;
BIDDISON, W ;
DEMARS, R ;
LONG, EO .
NATURE, 1992, 357 (6380) :702-704
[34]  
MALNATI MS, 1993, J IMMUNOL, V151, P6751
[35]   Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells [J].
Mautner, J ;
Pich, D ;
Nimmerjahn, F ;
Milosevic, S ;
Adhikary, D ;
Christoph, H ;
Witter, K ;
Bornkamm, GW ;
Hammerschmidt, W ;
Behrends, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) :2500-2509
[36]   Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis [J].
Mukherjee, P ;
Dani, A ;
Bhatia, S ;
Singh, N ;
Rudensky, AY ;
George, A ;
Bal, V ;
Mayor, S ;
Rath, S .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2632-2641
[37]   Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1 [J].
Münz, C ;
Bickham, KL ;
Subklewe, M ;
Tsang, ML ;
Chahroudi, A ;
Kurilla, MG ;
Zhang, D ;
O'Donnell, M ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (10) :1649-1660
[38]   IDENTIFICATION OF TARGET ANTIGENS FOR THE HUMAN CYTOTOXIC T-CELL RESPONSE TO EPSTEIN-BARR-VIRUS (EBV) - IMPLICATIONS FOR THE IMMUNE CONTROL OF EBV-POSITIVE MALIGNANCIES [J].
MURRAY, RJ ;
KURILLA, MG ;
BROOKS, JM ;
THOMAS, WA ;
ROWE, M ;
KIEFF, E ;
RICKINSON, AB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :157-168
[39]   Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy [J].
Nimmerjahn, F ;
Milosevic, S ;
Behrends, U ;
Jaffee, EM ;
Pardoll, DM ;
Bornkamm, GW ;
Mautner, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (05) :1250-1259
[40]   Inhibition of EBV-induced lymphoproliferation by CD4+ T cells specific for an MHC class II promiscuous epitope [J].
Omiya, R ;
Buteau, C ;
Kobayashi, H ;
Paya, CV ;
Celis, E .
JOURNAL OF IMMUNOLOGY, 2002, 169 (04) :2172-2179